Lipitor Weathers Crestor Launch; Lancet Weighs In On Pfizer’s Side
The early returns in the Lipitor versus Crestor marketing battle are running heavily in favor of Pfizer
The early returns in the Lipitor versus Crestor marketing battle are running heavily in favor of Pfizer